FDA Inspection 1098391 - Novartis Gene Therapies, Inc. - August 02, 2019

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Novartis Gene Therapies, Inc., with an inspection on August 2, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Novartis Gene Therapies, Inc.
Inspection Date: August 2, 2019
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · b248dcf9-f018-40c9-81cf-1316bcb9a3bf

Violation Codes5

21 CFR 211.160(a)21 CFR 211.19221 CFR 211.194(a)21 CFR 211.194(c)21 CFR 211.22(d)

Full citation text and observation details available on the Dashboard.